Rizaner, Nahit
Fraser, Scott P.
Gul, Ilknur Bugan
Purut, Esma
Djamgoz, Mustafa B. A. https://orcid.org/0000-0003-1435-8540
Altun, Seyhan
Article History
Received: 6 September 2023
Accepted: 25 November 2023
First Online: 2 January 2024
Declarations
:
: MBAD has a patent pending for use of blockers of the persistent component of the voltage-gated sodium channel as anti-metastatic agents. The other authors (NR, SPF, IBG, EP and SA) declare no conflict of interest.